May Measurement Month 2019: an analysis of blood pressure screening results from Lebanon.

Blood pressure Hypertension Lebanon Screening Treatment

Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 12 7 2021
pubmed: 13 7 2021
medline: 13 7 2021
Statut: epublish

Résumé

Hypertension is an important public health concern of high prevalence among adults. It is associated with an increased mortality rate. The prevalence of hypertension in Lebanon has increased during the last decades, affecting around one-third of the Lebanese population. Since diagnosis and treatment of hypertension is associated with a better prognosis, annual screening and raising awareness about this 'silent killer' disease is of extreme value. We conducted a cross-sectional survey in various Lebanese cities in 2019. We recruited adults (≥18 years old) from different sites, through an opportunistic sampling method. For each participant, three blood pressure (BP) readings were recorded and the average of the last two was analysed. In addition, data on lifestyle factors and comorbidities were collected. Participants were considered hypertensive if they had at least one of the following: systolic or diastolic BP ≥140 and

Identifiants

pubmed: 34248434
doi: 10.1093/eurheartj/suab037
pii: suab037
pmc: PMC8263084
doi:

Types de publication

Journal Article

Langues

eng

Pagination

B92-B94

Informations de copyright

Published on behalf of the European Society of Cardiology. © The Author(s) 2021.

Références

Int J Hypertens. 2018 Dec 26;2018:5419861
pubmed: 30729041
Prev Chronic Dis. 2014 Jul 17;11:E120
pubmed: 25032835
Ann Nutr Metab. 2010;57(3-4):193-203
pubmed: 21088386
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
J Hum Hypertens. 2005 Nov;19(11):861-8
pubmed: 16034449
Nurs Health Sci. 2014 Mar;16(1):126-30
pubmed: 24118852
Sci Rep. 2018 Jun 20;8(1):9418
pubmed: 29925884
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
J Clin Hypertens (Greenwich). 2015 May;17(5):381-8
pubmed: 25619545
Hypertension. 2020 Aug;76(2):333-341
pubmed: 32419505

Auteurs

Robert N Najem (RN)

Division of Nephrology, Department of Internal Medicine, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Lebanese Hospital Geitawi University Medical Center, Beirut, Lebanon.

Ahmad Halawi (A)

Department of Internal Medicine, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.

Bassem Tanios (B)

Division of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.

Rasha Ambriss (R)

Ministry of Public Health, Beirut, Lebanon.

Rana El Bikai (RE)

Public Health Department, Faculty of Health Sciences, University of Balamand, Beirut, Lebanon.

Giles Partington (G)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, London, UK.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, London, UK.
Department of Primary Care and Public Health, Imperial College London, London, UK.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, London, UK.

Ali K Abu Alfa (AKA)

Division of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.

Classifications MeSH